The invention concerns novel diarylselenide compounds corresponding to the general
formula (I) and the use thereof in pharmaceutical compositions in human or veterinary
medicine (in the treatment of dermatological, rheumatic, cardiovascular and ophthalmologic
pathologies in particular), or in cosmetic compositions.